MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with S

Safinamide

Safinamide 50mg tablets

No stability information

Stability notes for Safinamide 50mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Safinamide 50mg tablets
Safinamide 50mg tablets (A A H Pharmaceuticals Ltd)
Safinamide 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Safinamide 50mg tablets (Amarox Ltd)
Safinamide 50mg tablets (Celix Pharma Ltd)
Safinamide 50mg tablets (MSN Laboratories Europe Ltd)
Xadago 50mg tablets (Zambon UK Ltd)

Safinamide 100mg tablets

No stability information

Stability notes for Safinamide 100mg tablets

There are no stability notes for this medicine.

Suppliers (6) of Safinamide 100mg tablets
Safinamide 100mg tablets (A A H Pharmaceuticals Ltd)
Safinamide 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Safinamide 100mg tablets (Amarox Ltd)
Safinamide 100mg tablets (Celix Pharma Ltd)
Safinamide 100mg tablets (MSN Laboratories Europe Ltd)
Xadago 100mg tablets (Zambon UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.